CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
Article in Frontiers in Cell and Developmental Biology (March 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, and in vivo studies
Article in Journal of Drug Targeting (August 2022)
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Article in Biochemical Pharmacology (March 2022)